ASSOCIATION BETWEEN OBSTRUCTIVE SLEEP APNEA SEVERITY AND GLAUCOMA: A HOSPITAL-BASED CROSS-SECTIONAL STUDY

Main Article Content

Dr.Lumbini Devi Vattikonda
Dr.Sri Durga Saladi

Keywords

obstructive sleep apnea, glaucoma, primary open-angle glaucoma, apnea–hypopnea index, nocturnal hypoxemia, intraocular pressure, retinal nerve fiber layer, OCT

Abstract

Background: Obstructive sleep apnea (OSA) is characterized by recurrent upper-airway obstruction during sleep, intermittent hypoxemia and sleep fragmentation. Repeated nocturnal hypoxemia and vascular stress may affect the optic nerve and retinal circulation. Glaucoma, particularly primary open-angle glaucoma (POAG), is a chronic optic neuropathy in which vascular and pressure-related mechanisms may interact. The possible association between OSA severity and glaucoma is therefore clinically relevant to both respiratory medicine and ophthalmology.
Aim: To assess the association between OSA severity and glaucoma-related ophthalmic parameters in adults undergoing evaluation for suspected or confirmed OSA.
Methods: A hospital-based cross-sectional observational study was structured according to data collected. A fixed cohort of 100 adults with polysomnography-confirmed OSA was evaluated. Demographic data, BMI, smoking status, Epworth Sleepiness Scale (ESS), apnea–hypopnea index (AHI), oxygen-desaturation index (ODI), minimum nocturnal oxygen saturation, intraocular pressure (IOP), optic disc findings and optical coherence tomography (OCT) retinal nerve fiber layer (RNFL) thickness were recorded. Glaucoma was defined using a combined ophthalmic assessment including characteristic optic nerve/RNFL changes and corresponding visual-field abnormality, with IOP considered as a risk-related parameter.
Results: The cohort had a mean age of 56.7 ± 9.4 years and mean BMI of 29.1 ± 4.5 kg/m². Mild, moderate and severe OSA were present in 28%, 36%  and 36%, respectively. Glaucoma was identified in 15% overall. Prevalence increased from 3.6% in mild OSA to 13.9% in moderate OSA and 25.0% in severe OSA (p=0.031). Mean IOP was 15.8 ± 2.4, 16.7 ± 2.6 and 18.1 ± 3.0 mmHg in mild, moderate and severe OSA, respectively. Mean global RNFL thickness was progressively lower with increasing OSA severity. AHI and ODI were inversely correlated with global RNFL thickness and positively associated with IOP.
Conclusion: Greater OSA severity was associated with a higher prevalence of glaucoma and adverse ophthalmic parameters in this cohort. Nocturnal hypoxemia may represent an important pathway linking OSA to optic nerve vulnerability.


 


 

Abstract 0 | PDF Downloads 0

References

1. Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383(9918):736-747. doi:10.1016/S0140-6736(13)60734-5.
2. Senaratna CV, Perret JL, Lodge CJ, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017;34:70-81. doi:10.1016/j.smrv.2016.07.002.
3. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235.
4. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien, IL: AASM; 2014.
5. Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901-1911.
6. Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121(11):2081-2090.
7. Stein JD, Kim DS, Mundy KM, et al. The association between sleep apnea and glaucoma in a large national database. Ophthalmology. 2011;118(12):2479-2485.
8. Lin PW, Friedman M, Lin HC, Chang HW, Wilson MH. Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome. J Glaucoma. 2011;20(9):553-558.
9. Sergi M, Salerno DE, Rizzi M, et al. Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients. J Glaucoma. 2007;16(1):42-45.
10. Kadyan A, Asghar J, Dowson L, et al. Ocular findings in sleep apnea syndrome. Eye (Lond). 2010;24:843-849.
11. Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28(1):34-62.
12. Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J. 2013;4:14.
13. Choudhury N, et al. Association between obstructive sleep apnea and glaucoma: a systematic review and meta-analysis. [Peer-reviewed systematic review literature on OSA and glaucoma].
14. Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 Update. Am J Respir Crit Care Med. 2019;200(8):e70-e88.
15. Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499.
9. References
1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Prevention, Diagnosis and Management of COPD: 2012 Report. GOLD; 2012.
2. Agustí A, Celli BR, Criner GJ, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J. 2016;61(4):2300239.
3. Soğut S, et al. Evaluation of retinal microvasculature according to stable chronic obstructive pulmonary disease severity and the correlation of pulmonary parameters with optical coherence tomography angiography findings. [Study indexed in PubMed PMID: 35502048].
4. Kocak N, et al. The alterations of retinal vasculature detected on optical coherence tomography angiography associated with chronic obstructive pulmonary disease. [Study indexed in PubMed PMID: 35146915].
5. Ozturk M, et al. Retinal Vascular Changes in Patients with Chronic Obstructive Pulmonary Disease: An Optical Coherence Tomography Angiography Study. [Study indexed in PubMed PMID: 34349598].
6. McKay GJ, et al. Simple non-mydriatic retinal photography is feasible and demonstrates retinal microvascular dilation in Chronic Obstructive Pulmonary Disease (COPD). [Study indexed in PubMed PMID: 31923188].
7. Investigation of ocular microstructural changes according to disease severity in patients with chronic obstructive pulmonary disease. [Study indexed in PubMed PMID: 36306881].
8. The evaluation of retinal and choroidal structural changes by optical coherence tomography in patients with chronic obstructive pulmonary disease. [Study indexed in PubMed PMID: 28956644].
9. Alterations of retinal microvascular density in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Prog Med? Drug Discov? 2014; DOI:10.1016/j.pdpdt.2012.104690.
10. Skin autofluorescence as a measure of advanced glycation end-products is associated with microvascular health in patients with COPD. [Indexed in PubMed PMID: 32763256].
11. Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 Update. Am J Respir Crit Care Med. 2019;200(8):e70-e88.
12. Stanojevic S, Kaminsky DA, Miller MR, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499.
13. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435-459.
14. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765-773.
15. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645-1648. doi:10.1136/bmj.1.6077.1645.